Joint Iran-Cuba Vaccine Fully Efficient against New Variant of COVID-19

Joint Iran-Cuba Vaccine Fully Efficient against New Variant of COVID-19
By: 
Fecha de publicación: 
5 February 2022
0
Imagen principal: 

Pasteurcovac vaccine, jointly developed by Iran and Cuba, has proved to be 100% effective against Omicron variant of the COVID-19, Biglari told reporters via videoconference on Saturday.

He said that Pasteurcovac is permitted to be injected to children and adults.

He described Pasteurcovac as the safest vaccine against coronavirus, saying it had been tested against Beta Variant in Cuba and against Delta Variant in Iran and had been proved to be 96% effective.

Biglari went on to say that five million doses of Pasteurcovac vaccine is produced monthly in Iran and two doses are enough for children.

He also stressed that adults should receive booster dose, adding that Pasteurcovac can be used as booster for all vaccines.

Pasteurcovac, known as Soberana 2 in Cuba, has jointly been developed by Iran and Cuba and successfully passed the third phase for clinical test.

Add new comment

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.